Į krepšelį BACE inhibitors and their use in the treatment of Alzheimer’s Disease BACE (²-site of APP cleaving enzyme) is a critical component in Alzheimer’s Disease (AD), and the development of BACE inhibitors shows great potential as a therapy for the disease. BACE: Lead Target for Orchestrated Therapy of Alzheimer’s Continue Reading